Los Angeles, CANCT06423430Now EnrollingIRB Ready

Treatment Resistant Depression Clinical Trial in Los Angeles, CA

Access cutting-edge treatment resistant depression treatment through this clinical trial at a research site in Los Angeles. Study-provided care at no cost to qualified participants.

Sponsored by Abbott Medical Devices

Quick Self-Assessment

See if you qualify for this Los Angeles location

Preparing your pre-screening questions…

Expert Care in Los Angeles

Access treatment resistant depression specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related treatment resistant depression treatment provided free

Apply for This Los Angeles Location

Check if you qualify for this treatment resistant depression clinical trial in Los Angeles, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Los Angeles

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Los Angeles site if eligible
  4. 4Begin participation

About This Treatment Resistant Depression Study in Los Angeles

The goal of this clinical trial is to evaluate the effectiveness and safety of bilateral stimulation of the subcallosal cingulate white matter (SCCwm) using Deep Brain Stimulation (DBS) as an adjunctive treatment of non-psychotic unipolar Major Depressive Disorder (MDD) in adults.

Sponsor: Abbott Medical Devices

Who Can Participate

Inclusion Criteria

The patient must be diagnosed with non-psychotic unipolar Major Depressive Disorder.
The patient must be in a major depressive episode for ≥12 months or have had at least 3 lifetime depressive episodes.
The patient has tried and failed a minimum of four different types of antidepressant treatments as measured by a tool designed for this purpose.
Depression medication and treatment regimen must be stable for a minimum of 4 weeks before the first baseline visit

Exclusion Criteria

Pregnant or those who plan to become pregnant during study
Presence of other anatomic or comorbid conditions, or other medical, social, or psychological conditions that could limit participation in the study or interfere with adherence to the study protocol.
Current or lifetime history of psychotic features in any Major Depressive Episode.
Has an intracranial Central Nervous System disease that impairs motor, sensory or cognitive function or that requires intermittent or chronic medication.
Significant acute suicide risk.
Diagnosis of Substance Use Disorder or Alcohol Use Disorder without sustained remission (12 months or longer).
Current and ongoing use of neurostimulation treatment that may interfere with DBS therapy/system.
Treatment with another investigational device or investigational drugs.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Los Angeles?

Yes, this clinical trial (NCT06423430) has an active research site in Los Angeles, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Treatment Resistant Depression Treatment Options in Los Angeles, CA

If you're searching for treatment resistant depression treatment options in Los Angeles, CA, this clinical trial (NCT06423430) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Los Angeles research site is actively enrolling participants for this clinical trial. You'll receive care from experienced treatment resistant depression specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all treatment resistant depression clinical trials near you to find additional studies recruiting in your area.

More Depression Trials in Los Angeles, CA

See all depression clinical trials recruiting in Los Angeles — not just this study.

Browse Depression Trials in Los Angeles →

Browse More Trials by Condition

Depression TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Los Angeles?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Los Angeles, CA